After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

Looking ahead, we are excited to start our Phase 1 trial of RT-114 containing a GLP-1/GLP-2 dual agonist for the treatment ... intended to replace subcutaneous injection or intravenous infusion of ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...